CLINICAL OUTCOMES AND ADVERSE DRUG REACTIONS IN COVID-19 PATIENTS TREATED WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ALONE OR COMBINED
Background. Use of Hydroxychloroquine with or without Azithromycin is repurposed in SARS-CoV-2 in the absence of definitive treatment. Objective. To evaluate the association between the use of Hydroxychloroquine and Azithromycin when given alone or in combination on clinical outcomes and adverse d...
Main Authors: | H. Rathi, P. Rathi, M. Biyani |
---|---|
Format: | Article |
Language: | English |
Published: |
Ukrmedknyha
2021-11-01
|
Series: | International Journal of Medicine and Medical Research |
Subjects: | |
Online Access: | https://ojs.tdmu.edu.ua/index.php/ijmr/article/view/11814 |
Similar Items
-
Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01) -
Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
by: Lagier JC, et al.
Published: (2022-05-01) -
Covid-19: Effects of Azithromycin/Hydroxychloroquine/Ivermectin in ambulatory and hospitalized patients
by: Henry Mejia-Zambrano, et al.
Published: (2021-10-01) -
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
by: Chunfeng Li, et al.
Published: (2020-08-01) -
Hydroxychloroquine and Azithromycin Treatment of Hospitalized Patients Infected with SARS-CoV-2 in Senegal from March to October 2020
by: Fabien Taieb, et al.
Published: (2021-06-01)